Nutritional C-Reactive Protein Ratio as a Prognostic Biomarker in Metastatic Colorectal Cancer: A Comprehensive Review
DOI:
https://doi.org/10.48047/ybfbht17Keywords:
Nutritional C-Reactive Protein Ratio , Metastatic Colorectal CancerAbstract
Background: Metastatic colorectal cancer (mCRC) remains a major global health burden, ranking among the leading causes of cancer-related deaths worldwide. Despite significant advances in systemic therapy, including cytotoxic chemotherapy, targeted agents, and immunotherapy, survival in advanced disease remains suboptimal. This unmet clinical need has intensified the search for reliable, inexpensive,and widely applicable
Downloads
References
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide. CA Cancer J Clin. 2021;71(3):209-249.
Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-1422.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
